ES8202546A1 - Metodo de producir derivados de tiazolidina - Google Patents

Metodo de producir derivados de tiazolidina

Info

Publication number
ES8202546A1
ES8202546A1 ES498320A ES498320A ES8202546A1 ES 8202546 A1 ES8202546 A1 ES 8202546A1 ES 498320 A ES498320 A ES 498320A ES 498320 A ES498320 A ES 498320A ES 8202546 A1 ES8202546 A1 ES 8202546A1
Authority
ES
Spain
Prior art keywords
carbon atoms
production
hydroxyl
gastric acid
acid secretion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES498320A
Other languages
English (en)
Spanish (es)
Other versions
ES498320A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of ES498320A0 publication Critical patent/ES498320A0/es
Publication of ES8202546A1 publication Critical patent/ES8202546A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/54—Nitrogen and either oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
ES498320A 1980-01-07 1981-01-05 Metodo de producir derivados de tiazolidina Expired ES8202546A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP76280A JPS5697277A (en) 1980-01-07 1980-01-07 Thiazolidine derivative

Publications (2)

Publication Number Publication Date
ES498320A0 ES498320A0 (es) 1982-02-01
ES8202546A1 true ES8202546A1 (es) 1982-02-01

Family

ID=11482698

Family Applications (1)

Application Number Title Priority Date Filing Date
ES498320A Expired ES8202546A1 (es) 1980-01-07 1981-01-05 Metodo de producir derivados de tiazolidina

Country Status (6)

Country Link
US (1) US4376777A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0032128A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5697277A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR228444A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK2281A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES8202546A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58118577A (ja) * 1982-01-07 1983-07-14 Takeda Chem Ind Ltd チアゾリジン誘導体
JPS58177983A (ja) * 1982-04-13 1983-10-18 Takeda Chem Ind Ltd チアゾリジン誘導体
WO1986002073A1 (en) * 1984-10-03 1986-04-10 Takeda Chemical Industries, Ltd. Thiazolidinedione derivatives, process for their preparation, and pharmaceutical composition containing same
US4738972A (en) * 1985-05-21 1988-04-19 Pfizer Inc. Hypoglycemic thiazolidinediones
HU210339B (en) * 1985-05-21 1995-03-28 Pfizer Process for preparing thiazolidinediones and their pharmaceutical compositions haring hypoglycemic effect
US5691367A (en) * 1985-08-09 1997-11-25 Eli Lilly And Company Aryl-substituted rhodanine derivatives
US5356917A (en) * 1985-08-09 1994-10-18 Eli Lilly And Company Aryl-substituted rhodanine derivatives
US5260445A (en) * 1987-09-04 1993-11-09 Beecham Group P.L.C. 2,4-thiazolidinediones
JPH01180102U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1988-06-02 1989-12-25
US5216002A (en) * 1989-12-21 1993-06-01 Eli Lilly And Company Method of treating inflammatory bowel disease
ATE146462T1 (de) * 1990-04-27 1997-01-15 Orion Yhtymae Oy Pharmakologisch aktive catecholderivate
JPH0463570U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1990-10-09 1992-05-29
US5158966A (en) * 1991-02-22 1992-10-27 The University Of Colorado Foundation, Inc. Method of treating type i diabetes
JPH066904A (ja) * 1991-03-01 1994-01-14 Hitachi Kiden Kogyo Ltd クリーンルーム用無人搬送車の無人給電装置
EP0915090A1 (en) * 1992-09-10 1999-05-12 Eli Lilly And Company Compounds useful as hypoglycemic agents and for treating Alzheimer's disease
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
US6251928B1 (en) * 1994-03-16 2001-06-26 Eli Lilly And Company Treatment of alzheimer's disease employing inhibitors of cathepsin D
CA2323889A1 (en) * 1997-03-12 1998-09-17 Robert W. Esmond A method for treating or preventing alzheimer's disease
NZ501163A (en) * 1997-06-18 2002-02-01 Smithkline Beecham P Treatment of diabetes with thiazolidinedione and sulphonylurea (glibenclamide, glipizide, gliclazide, glimepiride, tolazamide and tolbutamide
PT996444E (pt) * 1997-06-18 2007-06-08 Smithkline Beecham Plc Tratamento de diabetes com tiazolidinodiona e metformina
GB9715306D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment
GB9715295D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment
US20040058873A1 (en) * 1998-03-12 2004-03-25 Esmond Robert W. Method for treating or preventing Alzheimer's disease
US7105552B2 (en) 1998-05-08 2006-09-12 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
AR023700A1 (es) 1998-11-12 2002-09-04 Smithkline Beecham Plc Un procedimiento para preparar una composicion farmaceutica que comprende un sensibilizador de insulina
WO2000028989A1 (en) 1998-11-12 2000-05-25 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
GB9824893D0 (en) * 1998-11-12 1999-01-06 Smithkline Beckman Corp Novel method of treatment
US6191154B1 (en) 1998-11-27 2001-02-20 Case Western Reserve University Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases
US7407978B2 (en) 1999-04-06 2008-08-05 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
EP1109796A1 (en) * 1999-07-01 2001-06-27 Geron Corporation Telomerase inhibitors and methods of their use
JP2001072592A (ja) 1999-07-01 2001-03-21 Kyowa Hakko Kogyo Co Ltd テロメラーゼ阻害剤
US6680387B2 (en) * 2000-04-24 2004-01-20 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US6768008B2 (en) 2000-04-24 2004-07-27 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US6958355B2 (en) * 2000-04-24 2005-10-25 Aryx Therapeutics, Inc. Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
GB0014969D0 (en) 2000-06-19 2000-08-09 Smithkline Beecham Plc Novel method of treatment
AU2001294673A1 (en) 2000-09-21 2002-04-02 Aryx Therapeutics Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, andatherosclerosis
US6452014B1 (en) 2000-12-22 2002-09-17 Geron Corporation Telomerase inhibitors and methods of their use
US20060047000A1 (en) * 2001-04-24 2006-03-02 Aryx Therapeutics, Inc. Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
ATE377855T1 (de) * 2002-01-16 2007-11-15 Gen Electric Instrumententafelmittenstapel mit integrierter verdrahtung
US8268352B2 (en) * 2002-08-05 2012-09-18 Torrent Pharmaceuticals Limited Modified release composition for highly soluble drugs
US8216609B2 (en) * 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
AU2002339196A1 (en) * 2002-11-21 2004-06-15 Delavan Ltd Check valve
WO2005041951A2 (en) * 2003-10-28 2005-05-12 Rigel Pharmaceuticals, Inc. Rhodanine derivatives for use as antiviral agents
AR057324A1 (es) * 2005-05-27 2007-11-28 Wyeth Corp Tigeciclina y metodos para preparar 9-aminominociclina
WO2009105621A1 (en) * 2008-02-22 2009-08-27 The Ohio State University Research Foundation Androgen receptot-ablative agents
JP5847085B2 (ja) 2009-10-09 2016-01-20 ザ オハイオ ステート ユニバーシティー リサーチ ファウンデーション チアゾリジンジオンエネルギー制限模倣剤
US20120094959A1 (en) 2010-10-19 2012-04-19 Bonnie Blazer-Yost Treatment of cystic diseases
US10034868B2 (en) 2014-11-04 2018-07-31 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the prevention and the treatment of rapidly progressive glomerulonephritis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1284516A (fr) * 1957-11-20 1962-02-16 France Etat Produits utilisables notamment comme agents susceptibles d'agir sur la croissance des plantes et leur procédé de fabrication
NL265085A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1960-05-24
US3200126A (en) * 1963-05-31 1965-08-10 Warner Lambert Pharmaceutical 3-alkyl-5-amino-2, 4-thiazolidinediones
US3825553A (en) * 1970-05-05 1974-07-23 Rorer Inc William H Certain 5-arylthiazolidines
SU480711A1 (ru) * 1973-07-02 1975-08-15 Ленинградский Ордена Трудового Красного Знамени Технологический Институт Им.Ленсовета Способ получени производных 3-оксиметилтиазолиндиона-2,4
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative

Also Published As

Publication number Publication date
JPS6310702B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1988-03-08
ES498320A0 (es) 1982-02-01
JPS5697277A (en) 1981-08-05
EP0032128A1 (en) 1981-07-15
DK2281A (da) 1981-07-08
AR228444A1 (es) 1983-03-15
US4376777A (en) 1983-03-15

Similar Documents

Publication Publication Date Title
ES8202546A1 (es) Metodo de producir derivados de tiazolidina
AU557691B2 (en) 2-penem antibiotics and their oxa-aza-, and carba analogues
IE41528L (en) Furfuryl-benzomorphane derivatives.
IE40511L (en) Pyridyl piperidine derivatives
PT83104B (en) Novel guanidinomethylbenzoic acid derivatives
IE34807B1 (en) Substituted naphthylalkylamines
MY101993A (en) Cephalosporin ester derivatives their production and use.
DE3569528D1 (en) Penem derivatives, methods of producing them, their use and pharmaceutical compositions
ES429864A1 (es) Procedimiento para la obtencion de derivados cefem.
ES8400384A1 (es) Procedimiento para la preparacion de derivados de carbaciclina.
ES8505375A1 (es) Un procedimiento para obtener esteres de cefalosporina
ES8401957A1 (es) Procedimiento de preparacion de derivados del acido 2-tiofen-acetico.
JPS54106491A (en) Cephalosporin analog or its salt, their preparation, and prophylactics and remedies for microbisms consisting mainly of them
ES449446A1 (es) Un procedimiento para la produccion de acidos 1-oxo-1h-6-pi-peridinogicamente activos y esteres de los mismos.
IE43121L (en) Alkynes.
IE44999L (en) Hydrazinopyridazine derivatives.
EP0128027A3 (en) Cephalosporin esters, their production and use
ES8307819A1 (es) "un metodo de producir derivados de cefalosporina".
IE40722L (en) Indolopiperidino -alkylphenothiazines
ES8307812A1 (es) Un procedimiento para la preparacion de nuevos amidin derivados del acido clavulawilo.
EP0065270A3 (en) Process for the preparation of 7-(2-amino-2-phenylacetamido)cephem derivatives and their use for the preparation of antibacterial agents
ZA802913B (en) Clavulanic acid derivatives, their preparation and use
DE2963679D1 (en) Clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them
DE3469738D1 (en) Spirobenzofuranones, their production and use
ES8205220A1 (es) Procedimiento para la obtencion de esteres del acido succi- nico de efecto antibacterial y antiprotozoal